Latest Options News

L1 Long Short Fund Limited has updated its dividend notification to include the Dividend Reinvestment Plan price, confirming a fully franked quarterly payout and new issue securities.

Acrux Ltd reported a remarkable surge in licensing revenue from its topical generics portfolio alongside a strategic pivot towards innovative drug delivery R&D at its 2025 Annual General Meeting.

Patronus Resources has confirmed a standout uranium intercept of 10.76m at 2.95% U3O8 at its Thunderball deposit, spotlighting a newly identified Upper Lode and bolstering the prospect of a multi-deposit uranium district in the Northern Territory.

Bio-Gene Technology Limited has received a $519,500 R&D tax incentive from the Australian government, supporting its development of innovative bio-insecticides targeting insecticide resistance.

Forrestania Resources Limited has initiated an all-scrip off-market takeover offer for Kula Gold Limited, aiming to consolidate gold exploration assets across Western Australia. The offer, valued up to $58.7 million, comes with unanimous backing from Kula's board.

Forrestania Resources has updated the opening date of its Share Purchase Plan to 9 December 2025, aligning it with key corporate events and offering shareholders a chance to buy shares at $0.175 each alongside new option incentives.

Wesfarmers Limited announces a fully franked special dividend of AUD 0.40 per share alongside a $1.10 capital return, both payable on December 4, 2025. Eligible shareholders can participate in the Dividend Investment Plan for the dividend component, marking a significant move in the company’s 2025 capital management strategy.

Skylark Minerals has acquired a high-grade gold portfolio in Côte d'Ivoire, including a flagship project with a 364,600-ounce inferred resource, marking a significant step in its West African growth strategy. The company is fully funded to accelerate exploration in early 2026, targeting resource expansion and new discoveries.

Elementos Limited has announced a $2.9 million non-renounceable entitlement offer alongside a $6 million initial placement to fund key project developments, including the Oropesa Tin Project and Cleveland Tin and Tungsten Project.

Elementos Limited has secured a minimum $8.7 million capital raise led by Metals X, boosting its cash reserves to $12.5 million to advance key tin projects. The raise includes a $6 million unconditional placement and a pro-rata entitlement offer to shareholders.

Chariot Corporation and partners have formalized a phased small-scale mining initiative in Nigeria, aiming to unlock near-term lithium production while advancing larger exploration goals.

Cynata Therapeutics has completed the final patient visit in its Phase 3 trial for CYP-004, targeting knee osteoarthritis, with results expected in mid-2026. This milestone advances hopes for a disease-modifying therapy in a market desperate for new options.